CLINICAL_TRIALS
research
· 2024-10-15
Clinical Trial Update: Quantifying 18kDa TSPO Expression in the Lung in Pulmonary Artery Hypertension (PAH)
Summary
Imperial College London is conducting a study to quantify 18kDa TSPO expression in the lungs of people with Pulmonary Arterial Hypertension and healthy controls…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Imperial College London | Conditions: Pulmonary Arterial Hypertension, Healthy | Status: RECRUITING